226 related articles for article (PubMed ID: 35605349)
1. Treatment initiation and utilization patterns of pharmacotherapies for early-onset idiopathic restless legs syndrome.
Costales B; Vouri SM; Brown JD; Setlow B; Goodin AJ
Sleep Med; 2022 Aug; 96():70-78. PubMed ID: 35605349
[TBL] [Abstract][Full Text] [Related]
2. Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome.
Kim J; Hartzema AG
Sleep Med; 2018 Apr; 44():45-52. PubMed ID: 29530369
[TBL] [Abstract][Full Text] [Related]
3. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Sun Y; van Valkenhoef G; Morel T
Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
[TBL] [Abstract][Full Text] [Related]
4. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
[TBL] [Abstract][Full Text] [Related]
5. Restless legs syndrome: pathophysiology and modern management.
Nagandla K; De S
Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
Iftikhar IH; Alghothani L; Trotti LM
Eur J Neurol; 2017 Dec; 24(12):1446-1456. PubMed ID: 28888061
[TBL] [Abstract][Full Text] [Related]
7. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
8. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
Winkelman JW
Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
[TBL] [Abstract][Full Text] [Related]
9. Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.
Safarpour Y; Vaziri ND; Jabbari B
Tremor Other Hyperkinet Mov (N Y); 2023; 13():10. PubMed ID: 37008995
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for restless legs syndrome.
Ferini-Strambi L; Marelli S
Expert Opin Pharmacother; 2014 Jun; 15(8):1127-38. PubMed ID: 24745717
[TBL] [Abstract][Full Text] [Related]
11. Treating Severe Refractory and Augmented Restless Legs Syndrome.
Winkelman JW
Chest; 2022 Sep; 162(3):693-700. PubMed ID: 35609673
[TBL] [Abstract][Full Text] [Related]
12. Incident mental health episodes after initiation of gabapentinoids vs. dopamine agonists for early-onset idiopathic restless legs syndrome.
Costales B; Vouri SM; Brown JD; Setlow B; Goodin AJ
Psychiatry Res; 2023 Oct; 328():115479. PubMed ID: 37708806
[TBL] [Abstract][Full Text] [Related]
13. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
Bogan RK
Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
[TBL] [Abstract][Full Text] [Related]
14. Health care resource utilization and costs associated with restless legs syndrome among managed care enrollees treated with dopamine agonists.
Meyers J; Candrilli S; Allen R; Manjunath R; Calloway M
Manag Care; 2012 Oct; 21(10):44-51. PubMed ID: 23156076
[TBL] [Abstract][Full Text] [Related]
15. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Winkelman JW; Armstrong MJ; Allen RP; Chaudhuri KR; Ondo W; Trenkwalder C; Zee PC; Gronseth GS; Gloss D; Zesiewicz T
Neurology; 2016 Dec; 87(24):2585-2593. PubMed ID: 27856776
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome-current therapies and management of augmentation.
Trenkwalder C; Winkelmann J; Inoue Y; Paulus W
Nat Rev Neurol; 2015 Aug; 11(8):434-45. PubMed ID: 26215616
[TBL] [Abstract][Full Text] [Related]
17. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
[TBL] [Abstract][Full Text] [Related]
18. Restless legs syndrome: differential diagnosis and management with pramipexole.
Brindani F; Vitetta F; Gemignani F
Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
Dostal M; Weber-Schoendorfer C; Sobesky J; Schaefer C
Eur J Neurol; 2013 Sep; 20(9):1241-6. PubMed ID: 23083216
[TBL] [Abstract][Full Text] [Related]
20. Interventions for chronic kidney disease-associated restless legs syndrome.
Gopaluni S; Sherif M; Ahmadouk NA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010690. PubMed ID: 27819409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
